Biotech’s Dulcius Ex Asperis: The Way Through This Downturn (Bionic Reading)
The biotech sector is experiencing the most severe downturn of at least the last 20 years. There have been many other downturns in the more recent past, but this one is different. Here Peter Kolchinsky discusses why - and how we’ll rebound.